Teleflex Incorporated has announced a contract with Vizient, Inc. for the supply of its Central Venous Access Catheters and Arterial Catheters, effective January 1, 2025. Vizient, the largest provider ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...

WAYNE, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2024 Global Impact Report. The ...

Teleflex Incorporated has announced its agreement to acquire most of the Vascular Intervention business from BIOTRONIK SE & Co. KG for approximately €760 million, pending regulatory approvals and ...

Teleflex has signed definitive deals to sell its acute care, interventional urology and OEM units for $2.03 billion in cash, with about $1.8 billion expected after tax. The company plans to return up ...

Revenue (Vascular): $472.7 million, a 2.4% increase year-over-year. Revenue (Interventional): $427.5 million, an 8.1% increase year-over-year. Revenue (Surgical): $219.3 million, a 3.2% increase ...

Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode. At the end of the ...

Sometimes two is better than one. That’s Teleflex Medical’s current logic as the firm announced that it would split into two publicly traded companies. More specifically, the Wayne, PA-based company ...

Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter 2025 financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 26, ...